Europe's most valuable company Novo Nordisk reports a slight increase in profitsNovo Nordisk posted a slight increase in net profit for the second quarter and raised its forecast for the full year due to increased demand for its diabetes and obesity treatments.
Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul HolstGLP-1 research by Holst, Habener, Mojsov, Drucker led to revolutionary weight-loss drugs.